ArticleJournal of neurology2021

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus.

Diego Centonze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.